Evidence mapPaperPMID 42200039Full record

ReviewFrontiers in neuroscience2026

Application of neuromodulation techniques in irritable bowel syndrome.

Yingchun Zhang, Liyuan Gao, Xiaoguang Zhang, Wenkai Sun, Meng Wang, Tingting Zhang, Xiaoyu Wang

Abstract readReview
In one paragraph

Review in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yingchun Zhang *Department of Gastroenterology, Zhangjiagang Traditional Chinese Medicine Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, China.
Liyuan Gao *Department of Pharmacy, Zhangjiagang Traditional Chinese Medicine Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, China.
Xiaoguang Zhang *Department of Gastroenterology, Zhangjiagang Traditional Chinese Medicine Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, China.
Wenkai SunDepartment of Gastroenterology, Zhangjiagang Traditional Chinese Medicine Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, China.
Meng WangDepartment of Gastroenterology, Zhangjiagang Traditional Chinese Medicine Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, China.
Tingting ZhangDepartment of Neurology, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Xiaoyu WangDepartment of Gastroenterology, Zhangjiagang Traditional Chinese Medicine Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Irritable bowel syndrome (IBS) is a gut-brain interaction disorder characterized by abdominal pain/abdominal discomfort accompanied by changes in bowel motility. Its pathogenesis involves the interaction of multiple factors, including abnormalities of the brain-gut axis, intestinal microbiota dysbiosis, and visceral hypersensitivity. Traditional treatment strategies mainly focus on symptomatic relief, which have limitations such as insufficient targeting and significant side effects. Neuromodulation techniques, as an emerging treatment modality, modulate the central or peripheral nervous system through electrical and electromagnetic means, targeting key pathways of the brain-gut axis. These techniques can regulate gut motility and suppress inflammatory responses, thereby alleviating IBS symptoms. Currently, several techniques are widely applied, including electroacupuncture (EA), Sacral Nerve Stimulation (SNS), transcutaneous auricular vagus nerve stimulation (taVNS), and transcutaneous electrical nerve stimulation (TENS). Multiple clinical trials have confirmed their effectiveness in relieving abdominal pain, improving bowel dysfunction, and enhancing quality of life. However, there are still issues such as significant individual differences and insufficient long-term efficacy data. Future research should focus on the development of personalized treatment plans, exploration of combination therapy strategies, and technological innovation to further enhance their clinical value.

Indexed as

brain-gut axiselectroacupunctureirritable bowel syndromeneuromodulationsacral nerve stimulation (SNS)

Identifiers

PMID42200039
PMCPMC13199257

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.